chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Hives all over both arms, whole top half back, face and neck; Has bumpy scabs; Extreme itching; This is a spontaneous report from a contactable consumer, the patient. A 71-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613), via an unspecified route of administration to the right arm on 16Mar2021 (at the age of 71-years-old), as a single dose for COVID-19 immunisation. Medical history included high blood pressure. The patient had no allergies to medications, food, or other products. The patient had not received other vaccines within 4 weeks, prior to the COVID vaccine. Prior to vaccination, the patient had not been diagnosed with COVID-19. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202), via an unspecified route of administration to the right arm on 23Feb2021 at 1530 (at the age of 71-years-old), as a single dose for COVID-19 immunisation. Concomitant medications included colchicine (MANUFACTURER UNKNOWN), aspirin (MANUFACTURER UNKNOWN), Lipitor (MANUFACTURER UNKNOWN), Cozaar (MANUFACTURER UNKNOWN) and vitamin d (MANUFACTURER UNKNOWN) for an unknown indication. On 23Feb2021 at 2200, the patient experienced hives all over both arms, whole top half back, face and neck, had bumpy scabs and extreme itching. The event resulted in a visit to the doctor or other healthcare professional office/clinic. Since the vaccination, the patient was not tested for COVID-19. Therapeutic measures taken included Benadryl and cortisone cream for the events. The clinical outcome of the events of hives, scab and itching was not recovered at the time of reporting.   No follow-up attempts are needed. No further information is expected.
After completing last vaccine today, Hep A, Patient became pale, clammy, and appeared to have convulsions with hand and arms turned in and eyes shut for about 1 minute stated at 9:55 am. Got her to exam table with help and took b/p right arm lying down with legs raised b/p 90/60. Gave juice and pop tart when she started feeling better. b/p 120/60, 120/60, 114/64. She contacted friend to pick up and before leaving repeat b/p  100/70. She regained color and reported felling much better. She did report not eating prior to coming into the clinic today.
bilat knee pain & reports of effusion; seen 17AUG96-tx w/Ibuprofen, ice, rest;
Information has been received from a consumer concerning her daughter, a 21 year old female with no medical history or drug allergy who was vaccinated with all 3 doses (first dose on 16-JAN-2007) of GARDASIL.  There was no concomitant medication.  Subsequently the patient started loosing her hair in fall 2007, before getting the third dose, she always had very thick hair and she lost about 35-40% of it already.  The caller also mentioned that she started experiencing excessive bruising on her legs around the same time the hair loss started.  The bruising was all gone, and the hair was not coming out as bad as it use to.  She had multiple tests (including tested vitamin levels (a little low on Biotin), thyroid test, Cushing's disease test, PCOS and urine test) done to see what was wrong.  She had thyroid test done and it did spike but when the second test was done it came back normal.  All other tests came back normal as well.  At the time of the report the patient was not recovered.  The patient sought medical attention.  Additional information has been requested.
pt started with rash around mouth  then with spread to trunk and back with fever of 101 given motrin  taken to ER and temp 104 rectally - given tylenol and monitored
This case was reported by a physician via call center representative and described the occurrence of pertussis in a 4-year-old male patient who received PEDIARIX (batch number AC21B408BA, expiry date 23rd January 2015). Co-suspect products included PEDIARIX. On 1st August 2013, the patient received the 1st dose of PEDIARIX. On an unknown date, the patient received the 2nd dose of PEDIARIX. In June 2015, 2 years after receiving PEDIARIX and not applicable after receiving PEDIARIX, the patient experienced pertussis (serious criteria GSK medically significant). On an unknown date, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the pertussis was not recovered/not resolved and the outcome of the drug dose administration interval too long was unknown. It was unknown if the reporter considered the pertussis to be related to PEDIARIX. It was unknown if the reporter considered the drug dose administration interval too long to be related to PEDIARIX. Additional information was provided Physician reported that a 4 year old patient had received only one dose of PEDIARIX on 01 August 2013. In June 2015, he had not received any subsequent dose, which led to a maladministration. At the time of reporting, the patient was in the clinic with pertussis. This was one of 2 cases reported by the same reporter.
My arm was sore the next morning, and it still sore as of today. My arm is red, puffy and hot now, I noticed it this morning. The evening after receiving the vaccine I felt really cold all over my body and went to bed.
DEVELOPED NODULE AT INJECTION SITE, 1 WEEK AFTER INJECTION. NO TREATMENT AT THIS TIME JUST MONITORING.
Subsequent to receiving vax, the pt developed an injection site reaction characterized by severe pain and swelling. As of 12/13/2000, the pts arm remained tender. No further information was available at the date of this report.
Tachycardia; Rapid heart rate; This spontaneous case was reported by a consumer and describes the occurrence of TACHYCARDIA (Tachycardia) and HEART RATE INCREASED (Rapid heart rate) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TACHYCARDIA (Tachycardia) and HEART RATE INCREASED (Rapid heart rate). At the time of the report, TACHYCARDIA (Tachycardia) and HEART RATE INCREASED (Rapid heart rate) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. No treatment information was provided. Action taken with mRNA-1273 in response to the events was unknown.
Developed a single hive on my neck on the same side I received the Pfizer Covid-19 vaccine (first dose)
Hives,Hives are on stomach,Great big red welts; Itching; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives,Hives are on stomach,Great big red welts) and PRURITUS (Itching) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014m20a) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-May-2021, the patient experienced URTICARIA (Hives,Hives are on stomach,Great big red welts) and PRURITUS (Itching). At the time of the report, URTICARIA (Hives,Hives are on stomach,Great big red welts) and PRURITUS (Itching) outcome was unknown.
Got her menstrual cycle back again; This is a spontaneous report received from a contactable consumer for a Pfizer sponsored program. The reporter is the patient.  A 64-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection), via an unspecified route of administration, administration date Apr2021 (Lot number: unknown) as dose 2, single for COVID-19 immunization; estrogens conjugated, medroxyprogesterone acetate (PREMPRO; Tablet), via an unspecified route of administration on an unspecified date (Lot number: unknown) as relief for menopause. Relevant medical history included: "Menopause" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: BNT162B2 (dose 1, single; lot number: unknown), administration date: Apr2021, for COVID-19 immunization. The following information was reported: The patient mentioned that the medication is estrogens conjugated, medroxyprogesterone acetate and she had been on it for about a month already at the time of the report. For some reason she got her menstrual cycle back again on an unspecified date. She used the medication from relief for menopause. The patient wanted to know is it normal to have a menstrual cycle again how long the bleeding will last. The patient mentioned that she got two shots of the Pfizer vaccine last Apr2021. She underwent routine vaccination and had no side effect. She wants to have the third shot and asked when will she get the approval to get the third Pfizer shot. The action taken for estrogens conjugated, medroxyprogesterone acetate was unknown. The outcome of the event was unknown.  Follow-up attempts are completed. No further information is expected.
Pediatrician working in the hospital. Was exposed the an office contact wo had covid.  Shoulder in soreness. At work on  Wednesday. Felt lightheaded had to sit in chair. That's all he reminders.  He workup to a CODE team putting oxygen on him. He has a seizure. Took the COVID test has COVID. Admitted to hospital for 2 days. Likely a syncopal  event.
Systemic: Confusion-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Nausea-Mild, Systemic: Vomiting-Mild
fever; sore injection site arm after each of her Covid-19 vaccines; This spontaneous case was reported by a patient and describes the occurrence of PYREXIA (fever) and VACCINATION SITE PAIN (sore injection site arm after each of her Covid-19 vaccines) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever) and VACCINATION SITE PAIN (sore injection site arm after each of her Covid-19 vaccines). At the time of the report, PYREXIA (fever) and VACCINATION SITE PAIN (sore injection site arm after each of her Covid-19 vaccines) outcome was unknown.            No concomitant drug was reported. The patient had her first booster dose of her Covid-19 vaccine on 24-Oct-2021. The patient was reporting fever, and sore injection site arm after each of her Covid-19 vaccines. No treatment drug was reported.   Reporter did not allow further contact
Redness, pain, swelling, itching, hard lump in right arm at injection site. Covid arm. Started about 2 days after worsening each day for a few days starting to go down still pain and itching and lump but getting smaller this is 8/10/21. Went to see doctor 8/06/21
This 68  year old  black male received the Pfizer Covid shot on  3/22/21    and went to the ED on 3/31/21     and was admitted  on 3/31/21 with the following diagnoses listed below. D69.6 - Thrombocytopenia, unspecified
No immediate common listed side effects.  Periodic tingling, deadness in arm.  Phoned the Clinic where vaccine was administered.  Was told that there was a possibility that a nerve was hit.   Have scheduled an appointment with my primary physician.
shingles all over; Pain; Burning; Tingling; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (shingles all over), PAIN (Pain), BURNING SENSATION (Burning) and PARAESTHESIA (Tingling) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001A21A and 028L20A) for COVID-19 vaccination.     Concomitant products included LISINOPRIL for Blood pressure management.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In March 2021, the patient experienced PAIN (Pain), BURNING SENSATION (Burning) and PARAESTHESIA (Tingling). On 26-Mar-2021, the patient experienced HERPES ZOSTER (shingles all over). The patient was treated with VALACICLOVIR HYDROCHLORIDE (VALTREX) at a dose of 1 dosage form; GABAPENTIN (NEURONTIN) at a dose of 1 dosage form; PREGABALIN (LYRICA) at a dose of 1 dosage form and PREDNISONE at a dose of 1 dosage form. At the time of the report, HERPES ZOSTER (shingles all over) had resolved and PAIN (Pain), BURNING SENSATION (Burning) and PARAESTHESIA (Tingling) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment included steroid cream.   Most recent FOLLOW-UP information incorporated above includes: On 18-May-2021: Follow up received on 18/05/2021 ADR form included with new events and treatments.
Thurs had severe bone & muscle pain-used APAP #3 3-had to go wear jacket last 2 hrs of shift secondary to chills; no fever; Friday couldn't get out of bed secondary/arthralgia (+) nausea; no vomiting-on Saturday dec myalgia but lt arm itchy
Course of Shingles  with Valacyclovir for 1 week.  After one week of drug symptoms subsided somewhat.  Still having residual pain and discomfort.
After vaccination, patient was in observation area then had a syncopal event for a few seconds and fell on the ground and hit the left side of his head. There are only superficial scrapes, no active bleeding. Patient claimed he had not eaten or drank any water then went for a 3 mile run before getting vaccinated. Vitals were normal: BP: 138/78, P: 95, O2 sat 96%, R: 20. Placed patient on yoga mat, gave water and snack, observed for 30 min. AOx4. Refused EMS and refused for his wife to pick him up and insisted on going home on his own.
Information has been received from a nurse concerning a patient who was vaccinated with a second dose of Rotateq. The patient was late for the second dose. The patient presented to the office later than 10 weeks post dose 1. The patient had no adverse experienced to report. Unspecified medical attention was sought. There was no product quality complaint involved. Additional information is not expected
About 5 weeks after receiving my second dose the hair on my head started falling out.  My hair is continuing to fall out; I am extremely distraught and upset; I am extremely distraught and upset; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0177) via an unspecified route of administration in the left arm on 17Jun2021 at 12:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication was not reported. The patient did not receive any other vaccines within four weeks prior to COVID-19 vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW001) via an unspecified route of administration in the left arm on 27May2021 at 12:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. On 02Aug2021, (also reported as about 5 weeks after receiving the second dose), the patient's hair on her head started falling out. The patient's hair was continuing to fall out and she went to her dermatologist who indicated that it was a result of the Pfizer COVID-19 vaccine. The dermatologist stated she has seen an unprecedented amount of hair loss from her patients and a strong correlation to those presenting with hair loss and receiving the vaccine. On an unknown date in 2021, the patient was extremely distraught and upset to be loosing her hair and required Pfizer to inform her how her hair loss will be halted and if/when her hair would come back. She was instructed to take hair loss supplements and required Pfizer to reimburse her for the out of pocket expenses for the hair loss supplement. The event hair on head started falling out resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the event hair on head started falling out with hair loss supplements. Therapeutic measures were not taken as a result of the events extremely distraught and upset to be loosing her hair. The clinical outcome of the events hair on head started falling out and extremely distraught and upset to be loosing her hair was not resolved at the time of this report.
Client received her first dose of COVID vaccine (Janssen on 04/09/21 lot: 1808980). Client requested to receive a Moderna COVID Vaccine Booster and a FLU shot. RN spoke with client about mixing of vaccines, and client did report that she did not have any adverse reaction with her Janssen COVID vaccine. RN administered Moderna Booster COVID vaccine Lot: 069H21A first and then the Fluarix Lot: 7557A to client. At 11:35 AM client complained of dizziness after the Fluarix was administered. RN then called both EMTs to bring the gravity chair to her station. Both EMTs stood near client to ensure client does not fall upon transfer to gravity chair and RN followed. Client reported that she ate this morning and did not have any reaction with a previous FLU shot nor with her Janssen COVID vaccine, client does not take any medications, no pertinent medical history and has no known allergies. 11:39 AM Vital Signs obtained: Oxygen Saturation: 98% on room air, Heart Rate: 58, Respiration Rate: 16 and Blood Pressure: 105/76. Skin is warm and dry and reported that she's feeling better. 11:45 AM Vital Signs obtained: Oxygen Saturation: 99% on room air, Heart Rate: 65, Respiration Rate: 18 and Blood Pressure: 105/73. Client did state, "I'm feeling better and the dizziness only lasted for a minute." Client was able to stand unassisted from gravity chair and no dizziness reported after client stood up. RN advised for client to stay another 15 minutes at observation area, so we can continue to monitor her; however client declined. RN and EMT then escorted client to the car where her father was waiting for her. Client was able to ambulate unassisted to their car. Client left facility at 11:50 AM.
Patient with 3 COVID vaccines who admitted to hospital with COVID detected PCR and dyspnea.  Provider d/c note:  "Patient with history of small cell lung carcinoma with mets, progressing to cause supraglottic airway narrowing. This caused patient to have hoarseness, shortness of breath, and difficulty swallowing. Patient also found to have COVID 19 pneumonia. In ED she received racemic epinephrine which subjectively helped, and she was sent to hospital for further evaluation and management. After CT neck imaging, patient debated transitioning to hospice care instead of continuing chemotherapy and further workup including ENT consult with direct layngoscopy. Patient did eventually decide to focus on comfort and further workup was cancelled.   Overnight last night she did have an episode of increased dyspnea after going to the bathroom. Was given anxiolytic which helped 'tremendously' per patient. She wishes to continue this if needed.   She has a history of pAfib on anticoagulation, hypertension, and anemia. Found to also have thrombocytopenia on labs on 9/20. For chronic problems she was continued on home medications. For new findings, no further workup was planned due to transition to hospice. Per patient preference no more labs or procedures were planned"
Mild headache; This case was reported by a consumer via call center representative and described the occurrence of headache in a 67-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On 18th November 2019, the patient received the 2nd dose of Shingrix. On 19th November 2019, 1 days after receiving Shingrix, the patient experienced headache. On an unknown date, the outcome of the headache was unknown.   It was unknown if the reporter considered the headache to be related to Shingrix.  Additional information was received as follows: The patient had the second dose of Shingrix yesterday and have a mild headache this morning. The patient enquired whether to take aspirin or ibuprofen to relieve headache.
On 9/26 /18--MMR, Flu vaccine given. On 10/1/18  fever started --T max 39 C. Rash started on  10/1/18 all over body then swelling over the face only.
This spontaneous report was received from a pharmacy technician refers to a patient of unknown age. The pharmacy technician reported that patient could not start a dose of ZOSTAVAX (lot number, expiry date and route was not reported) due to under filled sterile diluent issue. Pharmacy did not have any additional ZOSTAVAX to administer a dose for patient and patient was rescheduled to come back for a dose of OSTAVAX at a later date, no adverse effects were reported. Additional information is not expected.
got the flu shot but still got sick; Initial information received on 24-Nov-2022 regarding an unsolicited valid non-serious case received from a consumer via social media.   This case involves a patient of unknown age and unknown gender who reported got the flu shot but still got sick after receiving influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient had received an unknown dose of suspect influenza vaccine produced by unknown manufacturer (strength, route, formulation, batch number and expiry date: unknown) in unknown administration site for prophylactic vaccination.  On an unknown date, the patient reported got the flu shot but still got sick (illness) (latency: unknown) following the administration of influenza vaccine.  Lab tests were not reported.   Action taken: Not applicable.  It was not reported if the patient received a corrective treatment for the event (got the flu shot but still got sick).  At time of reporting, the outcome was unknown for the event.
Patient complained of mild abdominal discomfort 4-5 days after vaccine was administered and occasional irregular heart beat 2 weeks after vaccine was administered.
Dizziness, Headache, Sedation, Myalgia, Arthralgia, ErythemaMultiform, none Narrative:
Tested Positive for COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested Positive for COVID-19) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Tested Positive for COVID-19). At the time of the report, COVID-19 (Tested Positive for COVID-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Relevant concomitant medications were not reported.  Treatment information was not provided.